NVS
Novartis·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NVS Filings
Filing Date
Form Description
Form Type
2025-11-25
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-25 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-04 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-04
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025-11-04 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025-11-03
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-03 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-28
Novartis AG (NVS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-28 · Earnings Call
Novartis AG (NVS) Q3 2025 Earnings Call Transcript
2025-10-28
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
2025-10-28 ·
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
2025-10-28
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2025-10-28 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2025-10-28
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
2025-10-28 ·
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
